Korea to give medical suppliers better access to human-derived materials

2023. 11. 27. 12:39
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

The South Korean government will facilitate the better use of human-derived materials by business entities via its latest deregulation measure.

Human-derived materials refer to any parts of the human body, as well as secretions or excretions collected from the body, including blood, tissues, cells, and organs.

The current law requires manufacturers of in vitro diagnostic devices to submit requests to human-derived materials banks and undergo a rigorous review each time they need various materials for clinical testing during their product manufacturing.

But this practice caused inefficiencies, as manufacturers had to identify which banks have the materials they need and undergo the complicated application and safety review procedures.

As part of its effort to streamline the practice, the regulatory authority recently decided to set up a nationwide committee among the banks during the latest meeting moderated by Prime Minister Han Duck-soo on Sunday. The committee will have its office at the Daejeon Bio-Medical Regulation Free Special Zone, a district known for its regulatory sandbox approach, to review the requests.

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?